Douglas Nanton | Market Access and Government Affairs - Western Canada and Ottawa
Valeant Pharmaceuticals International
Former:
1) Senior staff member at Canadian Medical Association - Manitoba Division. Negotiator for collective agreements, physician procedural fees, and private service agreements
2) Executive Director, Manitoba Society of Pharmacists
3) Public Affairs & Reimbursement, GlaxoSmithKline
Current:
4) Valeant Canada, Market Access & Government Affairs - Western Canada & Ottawa
Appearances:
Pharma Pricing & Market Access USA Day 1 @ 12:30
Does Canada do it better - Payer partnerships and HTA in Canada – biosimilar market access
- Assess how payer partnerships narrow the network and patient assignments
- Improve patient outcomes and engagement through payer partnerships
- Decrease healthcare costs while remaining innovative by aligning payers with community partners
- Biosimilar examples
Pharma Pricing & Market Access USA Day 2 @ 14:30
PANEL: Market access evolution in Canada – past, present, and the future
- Ensure that prices at which pharmaceutical companies sell their patented medicines in Canada are not excessive
- Ensuring a sustainable pharmaceutical system where payers have the information they need to make smart reimbursement choices
- Ensuring effective access of your biosimilar into the marketplace
Organiser
